SlideShare a Scribd company logo
1 of 22
Detection of
Leishmania
Parasites via Flow
Cytometry
Analiese Wenger
What are Leishmania?
♦ Single-cell parasite
♦ Infect humans and other mammalian hosts
Life
Cycle
Leishmaniasis
♦ Manifestations:
• Cutaneous
• Mucosal
• Visceral
♦ Recognition of lipophosphoglycan (LPG)
♦ Promastigote engulfment
♦ Leishmania live in vesicles
protected from:
• Antibodies
• Killer T cells
♦ Inhibition of phagosome-endosome fusion
♦ Recognition of lipophosphoglycan (LPG)
♦ Promastigote engulfment
♦ Leishmania live in vesicles
protected from:
• Antibodies
• Killer T cells
♦ Inhibition of phagosome-endosome fusion
Immunological Subversion
Distribution
♦ 98 endemic countries
• 0.2 to 0.4 million new VL cases; 0.7 to 1.2 million new CL
cases each year worldwide
♦ Restricted to tropical and temperate regions
Scientific Question
Can macrophages infected with Leishmania be
detected using a flow cytometer?
Predictions and Hypotheses
♦ Predictions – The intracellular staining will
enable detection of Leishmania species inside
macrophages
♦ Alternative hypothesis – flow cytometry will
detect Leishmania
♦ Null hypothesis – flow cytometry will not detect
Leishmania
Flow Cytometry
♦ Counts individual cells using laser technology
• Forward-scattered light (FSC)
• Side-scattered light (SSC)
♦ Fluorescence dyes (fluorochromes) for sensing
target proteins
♦ Counts individual cells using laser technology
• Forward-scattered light (FSC)
• Side-scattered light (SSC)
♦ Fluorescence dyes (fluorochromes) for sensing
target proteins
Flow Cytometry Data
Experimental Design
♦ Macrophage Cells
• Mouse cell line J774A.1
♦ Leishmania species
• L. major - cutaneous
• L. infantum - visceral
Experimental Design
♦ L. major and L. infantum treatments:
• Control without fluorescein isothiocyanate
(FITC)
• Experimental group with FITC
♦ Anti-Leishmania (GP-63) Monoclonal
Antibody
♦ Visualized parasites following
flow acquisition
Techniques
♦ Preliminary experimentation
• FSC & SSC of macrophages
♦ Photomicroscopy
♦ Intracellular staining
• Modified protocol
FSC & SSC Results
Figure 1 Control J774 macrophages Figure 2 Macrophages infected with
L. major
Figure 3 Macrophages infected with
L. infantum
Figure 4 Macrophages infected with L.
infantum mixed with control
Figure 1 Control J774 macrophages Figure 2 Macrophages infected with
L. major
Figure 3 Macrophages infected with
L. infantum
Figure 4 Macrophages infected with L.
infantum mixed with control
Techniques
♦ Preliminary experimentation
• FSC & SSC of macrophages
♦ Photomicroscopy
♦ Intracellular staining
• Modified protocol
Photomicroscopy Results
L. major
L. infantum
Techniques
♦ Preliminary experimentation
• FSC & SSC of macrophages
♦ Photomicroscopy
♦ Intracellular staining
• Modified protocol
Parasite Flow Results
Figure 1 L. major: (left) without FITC and
(right) with FITC
Figure 2 L. infantum: (left) without FITC and
(right) with FITC
Figure 3 Histogram plot of L. major: (left)
without FITC and (right) with FITC
Figure 4 Histogram plot of L. infantum: (left)
without FITC and (right) with FITC
FL1 FL1
FL3
FL3
FL1 FL1 FL1 FL1
FL3
FL3
FL1FL1
Intracellular Staining Results
Figure 6 L. major infected macrophages
Figure 7 L. infantum infected macrophages Figure 8 L. infantum infected
macrophages mixed with control
Figure 5 Control macrophagesFigure 5 Control macrophages Figure 6 L. major infected macrophages
Figure 7 L. infantum infected macrophages Figure 8 L. infantum infected
macrophages mixed with control
Conclusions
♦ Anti-leishmania antibody does attach to the
major surface protease of L. infantum and L.
major
♦ L. infantum binds with higher specificity to
antibody than L. major
♦ Incomplete separation of infected versus
uninfected macrophages
Acknowledgements
• Dr. Gabrielle Stryker –
Mentor
• Dr. Blaise Dondji –
Leishmania expert & donor
• W. M. Keck Foundation and
Murdock Fund
• Mark Young – FlowJo
Wizard
• Eric Foss –
Photomicroscopy
Technician
• Heidi Anderson
• Mercedes Cheslock
References
Colomer - Gould, V., L. G. Quintao, J. Keithly, N. Nogueira. (1985). A
common surface antigen on amastigoes and promastigotes of
Leishmania species. J. Exp. Med., 162(902).
Desjardins, M., & Descoteaux, A. (1997). Inhibition of phagolysosomal
biogenesis by the Leishmania lipophosphoglycan. The Journal of
Experimental Medicine, 185(12), 2061–2068.
Russel, D.G., and H. Wilhelm. (1986). The involvement of the major
surface glycoprotein (gp63) of Leishmania in attachment to
macrophages. J. Immunol., 136(2616).
Kram, D., Thale, C., Kolodziej, H., and Kiderlen, A. (2008).
Intracellular parasite kill: Flow cytometry and NO detection for rapid
discrimination between anti-leishmanial activity and macrophage
activation. Journal of Immunological Methods, 333(20).
Questions?

More Related Content

What's hot

Combining Old and New: Sensitising Drugs and Other Vaccines To Augment Effica...
Combining Old and New: Sensitising Drugs and Other Vaccines To Augment Effica...Combining Old and New: Sensitising Drugs and Other Vaccines To Augment Effica...
Combining Old and New: Sensitising Drugs and Other Vaccines To Augment Effica...NeuroAcademy
 
The promise of mRNA vaccines
The promise of mRNA vaccinesThe promise of mRNA vaccines
The promise of mRNA vaccinesZeena Nackerdien
 
mRNA-based Therapeutics - Creative Biolabs
mRNA-based Therapeutics - Creative BiolabsmRNA-based Therapeutics - Creative Biolabs
mRNA-based Therapeutics - Creative BiolabsCreative-Biolabs
 
ProImmune Antigen Characterization Summit Paul Moss
ProImmune Antigen Characterization Summit Paul MossProImmune Antigen Characterization Summit Paul Moss
ProImmune Antigen Characterization Summit Paul Mossamandacturner
 
Viral Based Gene Delivery System for Car-t Cell Engineering
Viral Based Gene Delivery System for Car-t Cell Engineering Viral Based Gene Delivery System for Car-t Cell Engineering
Viral Based Gene Delivery System for Car-t Cell Engineering Creative-Biolabs
 
Level of Tumor Protein Indicates Chances Cancer Will Spread AND Malfunctionin...
Level of Tumor Protein Indicates Chances Cancer Will Spread AND Malfunctionin...Level of Tumor Protein Indicates Chances Cancer Will Spread AND Malfunctionin...
Level of Tumor Protein Indicates Chances Cancer Will Spread AND Malfunctionin...espontanea
 
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...Chi-Ping Day
 
Mcpyv Presentation
Mcpyv PresentationMcpyv Presentation
Mcpyv Presentationguesta37aeb
 
Gene therapy for NKTI Feb2013
Gene therapy for NKTI Feb2013Gene therapy for NKTI Feb2013
Gene therapy for NKTI Feb2013David Dy
 
Clinical molecular diagnostics for drug guidance
Clinical molecular diagnostics for drug guidanceClinical molecular diagnostics for drug guidance
Clinical molecular diagnostics for drug guidanceNikesh Shah
 
COVID-19: Biology, Transmission, and Detection
COVID-19: Biology, Transmission, and DetectionCOVID-19: Biology, Transmission, and Detection
COVID-19: Biology, Transmission, and DetectionAlejandroAlRuiz
 

What's hot (20)

Combining Old and New: Sensitising Drugs and Other Vaccines To Augment Effica...
Combining Old and New: Sensitising Drugs and Other Vaccines To Augment Effica...Combining Old and New: Sensitising Drugs and Other Vaccines To Augment Effica...
Combining Old and New: Sensitising Drugs and Other Vaccines To Augment Effica...
 
The promise of mRNA vaccines
The promise of mRNA vaccinesThe promise of mRNA vaccines
The promise of mRNA vaccines
 
mRNA-based Therapeutics - Creative Biolabs
mRNA-based Therapeutics - Creative BiolabsmRNA-based Therapeutics - Creative Biolabs
mRNA-based Therapeutics - Creative Biolabs
 
Zakir hcv
Zakir hcvZakir hcv
Zakir hcv
 
ProImmune Antigen Characterization Summit Paul Moss
ProImmune Antigen Characterization Summit Paul MossProImmune Antigen Characterization Summit Paul Moss
ProImmune Antigen Characterization Summit Paul Moss
 
Viral Based Gene Delivery System for Car-t Cell Engineering
Viral Based Gene Delivery System for Car-t Cell Engineering Viral Based Gene Delivery System for Car-t Cell Engineering
Viral Based Gene Delivery System for Car-t Cell Engineering
 
Level of Tumor Protein Indicates Chances Cancer Will Spread AND Malfunctionin...
Level of Tumor Protein Indicates Chances Cancer Will Spread AND Malfunctionin...Level of Tumor Protein Indicates Chances Cancer Will Spread AND Malfunctionin...
Level of Tumor Protein Indicates Chances Cancer Will Spread AND Malfunctionin...
 
Transformation by DNA and RNA viruses
Transformation by DNA and RNA viruses Transformation by DNA and RNA viruses
Transformation by DNA and RNA viruses
 
Oncogene activation
Oncogene  activationOncogene  activation
Oncogene activation
 
Suicide gene therapy
Suicide gene therapySuicide gene therapy
Suicide gene therapy
 
Oncogene
OncogeneOncogene
Oncogene
 
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...
 
Proof of concept of WGS based surveillance: meningococcal disease
Proof of concept of WGS based surveillance: meningococcal diseaseProof of concept of WGS based surveillance: meningococcal disease
Proof of concept of WGS based surveillance: meningococcal disease
 
Listeria monocytogenes from population structure to genomic epidemiology
Listeria monocytogenes from population structure to genomic epidemiologyListeria monocytogenes from population structure to genomic epidemiology
Listeria monocytogenes from population structure to genomic epidemiology
 
Mcpyv Presentation
Mcpyv PresentationMcpyv Presentation
Mcpyv Presentation
 
Gene therapy for NKTI Feb2013
Gene therapy for NKTI Feb2013Gene therapy for NKTI Feb2013
Gene therapy for NKTI Feb2013
 
Viral oncogenesis
Viral oncogenesisViral oncogenesis
Viral oncogenesis
 
Embed Repro Test
Embed Repro TestEmbed Repro Test
Embed Repro Test
 
Clinical molecular diagnostics for drug guidance
Clinical molecular diagnostics for drug guidanceClinical molecular diagnostics for drug guidance
Clinical molecular diagnostics for drug guidance
 
COVID-19: Biology, Transmission, and Detection
COVID-19: Biology, Transmission, and DetectionCOVID-19: Biology, Transmission, and Detection
COVID-19: Biology, Transmission, and Detection
 

Similar to 2015 Detection of Leishmania Parasites via Flow Cytometry Revise

Enzybiotics New era of antimicrobials.ppt
Enzybiotics New era of antimicrobials.pptEnzybiotics New era of antimicrobials.ppt
Enzybiotics New era of antimicrobials.pptMedhavi27
 
Pathology of JC Virus
Pathology of JC VirusPathology of JC Virus
Pathology of JC VirusYonah Ziemba
 
Cancer vaccine from mice to humans
Cancer vaccine from mice to humansCancer vaccine from mice to humans
Cancer vaccine from mice to humansHoussein A Sater
 
Rabies Virus_Presentation_by_Maliha_Rashid.pptx
Rabies Virus_Presentation_by_Maliha_Rashid.pptxRabies Virus_Presentation_by_Maliha_Rashid.pptx
Rabies Virus_Presentation_by_Maliha_Rashid.pptxMaliha Rashid
 
Optimizing antimicrobial therapy for hospitalized pneumonia: Focus on PK/PD p...
Optimizing antimicrobial therapy for hospitalized pneumonia: Focus on PK/PD p...Optimizing antimicrobial therapy for hospitalized pneumonia: Focus on PK/PD p...
Optimizing antimicrobial therapy for hospitalized pneumonia: Focus on PK/PD p...WAidid
 
Gene therapy by bdollar
Gene therapy by bdollarGene therapy by bdollar
Gene therapy by bdollarbernard bahaah
 
Molecular techniques for pathology research - MDX .pdf
Molecular techniques for pathology research - MDX .pdfMolecular techniques for pathology research - MDX .pdf
Molecular techniques for pathology research - MDX .pdfsabyabby
 
Alan Lesniewicz Memorial Lecture at UIC - July 2015
Alan Lesniewicz Memorial Lecture at UIC - July 2015Alan Lesniewicz Memorial Lecture at UIC - July 2015
Alan Lesniewicz Memorial Lecture at UIC - July 2015Cassandra Quave
 
Laboratory monitoring of Progression of HIV
Laboratory monitoring of  Progression of HIVLaboratory monitoring of  Progression of HIV
Laboratory monitoring of Progression of HIVAnkita Mohanty
 
Lymphoproliferative disorders DR MASOUD 2022.pptx
Lymphoproliferative disorders DR MASOUD 2022.pptxLymphoproliferative disorders DR MASOUD 2022.pptx
Lymphoproliferative disorders DR MASOUD 2022.pptxmasoud53
 
Viral Cultivation and Identification Technique.pptx
Viral Cultivation and Identification Technique.pptxViral Cultivation and Identification Technique.pptx
Viral Cultivation and Identification Technique.pptxMagAhmed
 
Novel biomarkers in Multiple sclerosis
Novel biomarkers in Multiple sclerosisNovel biomarkers in Multiple sclerosis
Novel biomarkers in Multiple sclerosisAmr Hassan
 
Humoral Immunodeficiencies
Humoral ImmunodeficienciesHumoral Immunodeficiencies
Humoral ImmunodeficienciesShobhita Katiyar
 
Humoral Immunodeficiencies
Humoral ImmunodeficienciesHumoral Immunodeficiencies
Humoral ImmunodeficienciesShobhita Katiyar
 
Uncultivable bacteria and recent trends towards their identification
Uncultivable bacteria and recent trends towards their identificationUncultivable bacteria and recent trends towards their identification
Uncultivable bacteria and recent trends towards their identificationabhishek yadav
 
Premalignant lesions and biopsy
Premalignant lesions and biopsyPremalignant lesions and biopsy
Premalignant lesions and biopsySujay Patil
 

Similar to 2015 Detection of Leishmania Parasites via Flow Cytometry Revise (20)

Enzybiotics New era of antimicrobials.ppt
Enzybiotics New era of antimicrobials.pptEnzybiotics New era of antimicrobials.ppt
Enzybiotics New era of antimicrobials.ppt
 
Pathology of JC Virus
Pathology of JC VirusPathology of JC Virus
Pathology of JC Virus
 
Cancer vaccine from mice to humans
Cancer vaccine from mice to humansCancer vaccine from mice to humans
Cancer vaccine from mice to humans
 
Rabies Virus_Presentation_by_Maliha_Rashid.pptx
Rabies Virus_Presentation_by_Maliha_Rashid.pptxRabies Virus_Presentation_by_Maliha_Rashid.pptx
Rabies Virus_Presentation_by_Maliha_Rashid.pptx
 
Optimizing antimicrobial therapy for hospitalized pneumonia: Focus on PK/PD p...
Optimizing antimicrobial therapy for hospitalized pneumonia: Focus on PK/PD p...Optimizing antimicrobial therapy for hospitalized pneumonia: Focus on PK/PD p...
Optimizing antimicrobial therapy for hospitalized pneumonia: Focus on PK/PD p...
 
Gene therapy by bdollar
Gene therapy by bdollarGene therapy by bdollar
Gene therapy by bdollar
 
Molecular techniques for pathology research - MDX .pdf
Molecular techniques for pathology research - MDX .pdfMolecular techniques for pathology research - MDX .pdf
Molecular techniques for pathology research - MDX .pdf
 
Alan Lesniewicz Memorial Lecture at UIC - July 2015
Alan Lesniewicz Memorial Lecture at UIC - July 2015Alan Lesniewicz Memorial Lecture at UIC - July 2015
Alan Lesniewicz Memorial Lecture at UIC - July 2015
 
VICERAL LEISHMANIASIS
VICERAL LEISHMANIASISVICERAL LEISHMANIASIS
VICERAL LEISHMANIASIS
 
HIV.pptx
HIV.pptxHIV.pptx
HIV.pptx
 
Monoclonal antibody
Monoclonal antibodyMonoclonal antibody
Monoclonal antibody
 
Laboratory monitoring of Progression of HIV
Laboratory monitoring of  Progression of HIVLaboratory monitoring of  Progression of HIV
Laboratory monitoring of Progression of HIV
 
Lymphoproliferative disorders DR MASOUD 2022.pptx
Lymphoproliferative disorders DR MASOUD 2022.pptxLymphoproliferative disorders DR MASOUD 2022.pptx
Lymphoproliferative disorders DR MASOUD 2022.pptx
 
Viral Cultivation and Identification Technique.pptx
Viral Cultivation and Identification Technique.pptxViral Cultivation and Identification Technique.pptx
Viral Cultivation and Identification Technique.pptx
 
monoclonalantibodies.ppt
monoclonalantibodies.pptmonoclonalantibodies.ppt
monoclonalantibodies.ppt
 
Novel biomarkers in Multiple sclerosis
Novel biomarkers in Multiple sclerosisNovel biomarkers in Multiple sclerosis
Novel biomarkers in Multiple sclerosis
 
Humoral Immunodeficiencies
Humoral ImmunodeficienciesHumoral Immunodeficiencies
Humoral Immunodeficiencies
 
Humoral Immunodeficiencies
Humoral ImmunodeficienciesHumoral Immunodeficiencies
Humoral Immunodeficiencies
 
Uncultivable bacteria and recent trends towards their identification
Uncultivable bacteria and recent trends towards their identificationUncultivable bacteria and recent trends towards their identification
Uncultivable bacteria and recent trends towards their identification
 
Premalignant lesions and biopsy
Premalignant lesions and biopsyPremalignant lesions and biopsy
Premalignant lesions and biopsy
 

2015 Detection of Leishmania Parasites via Flow Cytometry Revise

  • 1. Detection of Leishmania Parasites via Flow Cytometry Analiese Wenger
  • 2. What are Leishmania? ♦ Single-cell parasite ♦ Infect humans and other mammalian hosts Life Cycle
  • 4. ♦ Recognition of lipophosphoglycan (LPG) ♦ Promastigote engulfment ♦ Leishmania live in vesicles protected from: • Antibodies • Killer T cells ♦ Inhibition of phagosome-endosome fusion ♦ Recognition of lipophosphoglycan (LPG) ♦ Promastigote engulfment ♦ Leishmania live in vesicles protected from: • Antibodies • Killer T cells ♦ Inhibition of phagosome-endosome fusion Immunological Subversion
  • 5. Distribution ♦ 98 endemic countries • 0.2 to 0.4 million new VL cases; 0.7 to 1.2 million new CL cases each year worldwide ♦ Restricted to tropical and temperate regions
  • 6. Scientific Question Can macrophages infected with Leishmania be detected using a flow cytometer?
  • 7. Predictions and Hypotheses ♦ Predictions – The intracellular staining will enable detection of Leishmania species inside macrophages ♦ Alternative hypothesis – flow cytometry will detect Leishmania ♦ Null hypothesis – flow cytometry will not detect Leishmania
  • 8. Flow Cytometry ♦ Counts individual cells using laser technology • Forward-scattered light (FSC) • Side-scattered light (SSC) ♦ Fluorescence dyes (fluorochromes) for sensing target proteins ♦ Counts individual cells using laser technology • Forward-scattered light (FSC) • Side-scattered light (SSC) ♦ Fluorescence dyes (fluorochromes) for sensing target proteins
  • 10. Experimental Design ♦ Macrophage Cells • Mouse cell line J774A.1 ♦ Leishmania species • L. major - cutaneous • L. infantum - visceral
  • 11. Experimental Design ♦ L. major and L. infantum treatments: • Control without fluorescein isothiocyanate (FITC) • Experimental group with FITC ♦ Anti-Leishmania (GP-63) Monoclonal Antibody ♦ Visualized parasites following flow acquisition
  • 12. Techniques ♦ Preliminary experimentation • FSC & SSC of macrophages ♦ Photomicroscopy ♦ Intracellular staining • Modified protocol
  • 13. FSC & SSC Results Figure 1 Control J774 macrophages Figure 2 Macrophages infected with L. major Figure 3 Macrophages infected with L. infantum Figure 4 Macrophages infected with L. infantum mixed with control Figure 1 Control J774 macrophages Figure 2 Macrophages infected with L. major Figure 3 Macrophages infected with L. infantum Figure 4 Macrophages infected with L. infantum mixed with control
  • 14. Techniques ♦ Preliminary experimentation • FSC & SSC of macrophages ♦ Photomicroscopy ♦ Intracellular staining • Modified protocol
  • 16. Techniques ♦ Preliminary experimentation • FSC & SSC of macrophages ♦ Photomicroscopy ♦ Intracellular staining • Modified protocol
  • 17. Parasite Flow Results Figure 1 L. major: (left) without FITC and (right) with FITC Figure 2 L. infantum: (left) without FITC and (right) with FITC Figure 3 Histogram plot of L. major: (left) without FITC and (right) with FITC Figure 4 Histogram plot of L. infantum: (left) without FITC and (right) with FITC FL1 FL1 FL3 FL3 FL1 FL1 FL1 FL1 FL3 FL3 FL1FL1
  • 18. Intracellular Staining Results Figure 6 L. major infected macrophages Figure 7 L. infantum infected macrophages Figure 8 L. infantum infected macrophages mixed with control Figure 5 Control macrophagesFigure 5 Control macrophages Figure 6 L. major infected macrophages Figure 7 L. infantum infected macrophages Figure 8 L. infantum infected macrophages mixed with control
  • 19. Conclusions ♦ Anti-leishmania antibody does attach to the major surface protease of L. infantum and L. major ♦ L. infantum binds with higher specificity to antibody than L. major ♦ Incomplete separation of infected versus uninfected macrophages
  • 20. Acknowledgements • Dr. Gabrielle Stryker – Mentor • Dr. Blaise Dondji – Leishmania expert & donor • W. M. Keck Foundation and Murdock Fund • Mark Young – FlowJo Wizard • Eric Foss – Photomicroscopy Technician • Heidi Anderson • Mercedes Cheslock
  • 21. References Colomer - Gould, V., L. G. Quintao, J. Keithly, N. Nogueira. (1985). A common surface antigen on amastigoes and promastigotes of Leishmania species. J. Exp. Med., 162(902). Desjardins, M., & Descoteaux, A. (1997). Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. The Journal of Experimental Medicine, 185(12), 2061–2068. Russel, D.G., and H. Wilhelm. (1986). The involvement of the major surface glycoprotein (gp63) of Leishmania in attachment to macrophages. J. Immunol., 136(2616). Kram, D., Thale, C., Kolodziej, H., and Kiderlen, A. (2008). Intracellular parasite kill: Flow cytometry and NO detection for rapid discrimination between anti-leishmanial activity and macrophage activation. Journal of Immunological Methods, 333(20).

Editor's Notes

  1. Leishmaniasis is transmitted by the bite of infected female phlebotomine sandflies. The sandflies inject the infective stage (i.e., promastigotes) from their proboscis during blood meals . Promastigotes that reach the puncture wound are phagocytized by macrophages and other types of mononuclear phagocytic cells. Progmastigotes transform in these cells into the tissue stage of the parasite (i.e., amastigotes) , which multiply by simple division and proceed to infect other mononuclear phagocytic cells . Parasite, host, and other factors affect whether the infection becomes symptomatic and whether cutaneous or visceral leishmaniasis results. Sandflies become infected by ingesting infected cells during blood meals (, ). In sandflies, amastigotes transform into promastigotes, develop in the gut (in the hindgut for leishmanial organisms in the Viannia subgenus; in the midgut for organisms in the Leishmania subgenus), and migrate to the proboscis .
  2. The parasites cause a complex of diseases called leishmaniasis
  3. We show that LPG repeating units enable Leishmania to inhibit the phagosome-endosome fusion process efficiently, thereby suggesting a survival strategy during their differentiation into amastigotes. L inhabit mo intracellularly which protects from other immune respones.